PER 1.41% 7.0¢ percheron therapeutics limited

Boomy,I Will state the value first but please see the reasoning...

  1. 300 Posts.
    lightbulb Created with Sketch. 833
    Boomy,

    I Will state the value first but please see the reasoning below.

    Somewhere in the US$1.1bn to US$1.4bn range.But it would have to be proceeded by LGMD going into a P2 and a US licensing deal for DMD. Obviously the buyer would be the licensor.

    Akki is somewhat right in that we aren’t getting a $1.50 to $2.00 takeover when we are at 7c… although the largest premium for a takeover was in 2016 which was 1532%.

    Need to create more value first. If we do end up going it alone all the way to approval, price could be a fair bit higher.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.